Rose-Marie Rébillard

5PUBLICATIONS
57CO-AUTHORS
Haematological tumoursCardiology (incl. cardiovascular diseases)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 15, 2025
Blood Biomarkers to Identify Renal Angiomyolipomas in People With Tuberous Sclerosis Complex.

Renaud Balthazard, Jimmy Li, Frédéric Loubert

|Jul 03, 2025
Peripheral HLA-DRhiCD141+ Classical Monocytes Predict Relapse Risk and Worsening in Multiple Sclerosis.

Karine Thai, Rose-Marie Rebillard, Wendy Klement

|Jan 05, 2022
DICAM promotes TH17 lymphocyte trafficking across the blood-brain barrier during autoimmune neuroinflammation.

Marc Charabati, Camille Grasmuck, Soufiane Ghannam

|Nov 26, 2021
Integrated immunovirological profiling validates plasma SARS-CoV-2 RNA as an early predictor of COVID-19 mortality.

Elsa Brunet-Ratnasingham, Sai Priya Anand, Pierre Gantner

|Apr 28, 2020
Polygenic risk scores of several subtypes of epilepsies in a founder population.

Claudia Moreau, Rose-Marie Rébillard, Stefan Wolking

Pageof 1